Despite this, there are encouraging evidences that brain insulin resistance can at least partially be overcome by I-I, as shown in the clinic and under experimental conditions, which is important in the treatment of both AD and diabetic pathology that are characterized by the decreased insulin sensitivity in the CNS [121]. Here, INS is linked to Alzheimer disease.